| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |